Health
US Pauses Chikungunya Vaccine Over Severe Side Effects
US health authorities have suspended the license for the Ixchiq vaccine against the chikungunya virus following reports of “serious adverse events”, the drug’s French maker said Monday.
Ixchiq is one of just two vaccines approved by the US Food and Drug Administration for the mosquito-spread virus, which mainly occurs in tropical and subtropical regions but has recently been discovered to countries worldwide.
French company Valneva obtained US approval for the vaccine in 2023, but reports of side effects have prompted reviews in particular over its use in older patients, including by the European Medicines Agency this year.
“The suspension of the license is effective immediately,” Valneva said of the FDA order issued Friday, citing four additional cases of serious side effects, three of which involved people aged 70 to 82.
“As we determine potential next steps, and as the clear threat of chikungunya continues to escalate globally, Valneva remains fully committed to maintaining access to our vaccine as a global health tool,” chief executive Thomas Lingelbach said in a statement.
Public health experts say chikungunya could be a potential future pandemic threat as climate change pushes the mosquitoes that spread it into new regions.
The symptoms are similar to those of dengue fever and Zika virus, with high fever and severe joint pain that is often debilitating and varies in duration.
Chikungunya is rarely fatal, though there is an increased risk of death for babies and the elderly.
In July, the World Health Organization warned of the risks of a major chikungunya epidemic, calling for urgent action.
The agency said it was picking up the same early warning signs as in a major outbreak two decades ago, which swept across the Indian Ocean before spreading globally and affecting almost half a million people.
So far this year, Europe has seen 27 chikungunya outbreaks, a new record for the continent, the European Centre for Disease Prevention and Control said this month.
AFP
Health
Gov Mbah Invest in world-class Enugu International Hospital
The hospital, equipped with state-of-the-art medical equipment and advanced digital and electronic systems, is expected to attract top medical professionals from Nigeria and around the world.
Enugu State Governor, Peter Mbah, says the Enugu International Hospital is designed to provide world-class healthcare services to people across all socioeconomic classes.
The Enugu International Hospital is located at Rangers Avenue, Independence Layout, Enugu.
Mbah stated this during a pre-launch tour of the facility ahead of its official commissioning.
The hospital, equipped with state-of-the-art medical equipment and advanced digital and electronic systems, is expected to attract top medical professionals from Nigeria and around the world.
The governor expressed satisfaction with the quality of the equipment installed at the facility, saying the investment would help position Enugu as a medical tourism hub in Nigeria.
He said the hospital would also help reduce the number of Nigerians travelling abroad for specialist medical treatment while creating an environment that would encourage Enugu-trained medical professionals to return home.
According to Mbah, several Enugu-qualified medical practitioners based abroad have already reached out to express interest in working at the international hospital and contributing to the development of the state’s health sector.
The governor further said the facility would create job opportunities for medical graduates, healthcare professionals and other workers, with the potential to boost economic activity in the state.
During the tour, Mbah inspected several specialist units, including the Precision Oncology and Nuclear Medicine Unit, specialised surgery theatres, intensive care units, advanced diagnostics and imaging, and renal care and dialysis facilities.
He also toured the cancer, heart and vascular, nuclear medicine and molecular imaging, neuroscience, and renal centres.
Accompanied by the Director of the facility, Professor Sam Agwu, and other specialists, the governor received briefings on the various services and specialist care the hospital is expected to provide.
The Enugu International Hospital operates as a comprehensive quaternary care facility with more than 300 beds and was established to provide world-class specialist healthcare.
The facility is expected to strengthen access to advanced medical care, support medical professionals, create employment and contribute to Enugu State’s emergence as a destination for medical tourism.
Health
Bayer to establish reproductive health commodities plant in Nigeria
The plant is expected to manufacture family planning commodities locally, reducing Nigeria’s dependence on imported products, creating jobs and contributing to economic growth.
•The Minister of Health and Social Welfare, Prof. Muhammad Pate
Global pharmaceutical company, Bayer, is to establish a reproductive health commodities manufacturing plant in Nigeria, with the facility currently under construction in Anambra State.
The plant is expected to manufacture family planning commodities locally, reducing Nigeria’s dependence on imported products, creating jobs and contributing to economic growth.
The Minister of Health and Social Welfare, Prof. Muhammad Pate, disclosed this in Abuja at the inauguration of the High-Level Inter-Ministerial Platform (IMP) on Family Planning, Health, Human Capital and Sustainable National Development.
Pate described the investment as evidence that President Bola Tinubu’s Executive Order on the pharmaceutical sector was beginning to attract significant investments in local pharmaceutical manufacturing, diagnostics and health technology.
Also speaking, the Managing Director of FP2030 West and Central Africa Office, Dr Alain Damiba, described the initiative as a major step towards strengthening cross-sector collaboration to improve health outcomes and accelerate Nigeria’s socio-economic development.
Damiba commended the Federal Government for adopting a whole-of-government approach, noting that the new platform demonstrated that health and family planning were national development priorities and not issues that should be left to the health sector alone.
“Health, including family planning, is a smart investment in human capital and Nigeria’s future,” Damiba said.
Source: The Guardian Nigeria
Health
Medical Oxygen Killing More Than 600,000 Nigerians Annually
The project started its first phase by carrying out intervention work in three industrial areas of the state: quarry industrial site in Onueke, rice mill in Abakaliki, and timber market
•Professor Jesse Uneke
The Vice Chancellor of David Umahi Federal University of Health Sciences (DUFUS), Ebonyi State, Professor Jesse Uneke, has estimated that more than 600,000 Nigerians died yearly due to issues relating to the administration of medical oxygen.
Uneke, who is the Nigerian and State Lead/Principal Investigator for the EQUI-RESP Africa Research Project, disclosed this in Abakaliki, during the First Stakeholders’ Engagement Event/Co-Creation Workshop on Medical Oxygen Economy organised by the university in conjunction with the University of Edinburgh, UK, supported by the National Institute for Health and Research (NIHR), UK.
He explained that the administration of medical oxygen issues was happening because there was no platform where stakeholders in the medical oxygen space could come together to discuss the research-policy interface and see how to contextualise some of the strategies against the problems for the country.
“That is why, in this phase of this project, we have decided to start with this kind of stakeholders’ engagement. I am excited that we have every key stakeholder in the medical oxygen space represented here,” Uneke said.
He opined that the project started its first phase by carrying out intervention work in three industrial areas of the state: quarry industrial site in Onueke, rice mill in Abakaliki, and timber market.
This project has to do with respiratory health, and the idea is to come up with strategies that will lead to interventions that will improve health outcomes as far as respiratory health is concerned.
-
Business2 days agoNaira Exchange Rates Today, Monday August 31
-
Business3 days agoPZ Cussons Reports N45.2bn PAT, Proposes N2.50 Dividend
-
News2 days agoJAMB introducing facial scan to catch UTME impersonators
-
Business1 day agoCommercial Banks Borrowing From CBN Drops By 89% in August
-
Business2 days agoEmzor Pharma raises N26.7bn bond to boost local drug manufacturing
-
Entertainment2 days agoDolly Parton Buried By Husband’s Grave In Private Cemetry
-
Politics2 days agoG100 Opposition Summit Proposes Single 4-year Term
-
Business2 days agoNigeria’s GDP grew 4.43% in Q2 2026, says NBS
